Clene Inc.: Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8 Treatment
Clene, Inc. (Nasdaq: CLNN) and its subsidiary, Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment ...
ALS News Today32m
Legislation seeks access to benefits for spouses of veterans with ALS
Under current regulations, spouses can receive benefits only if the veteran lived with the disability for at least eight years before dying.
Cognixion Launches Clinical Trial for Late-Stage ALS to Deliver Conversation Level Communication with Adaptive AI-Driven Brain-Computer Interface
The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic lateral sclerosis (ALS) patients, who have lost natural speech, to communi ...
Le Lézard1h
Mitsubishi Tanabe Pharma America to Showcase New Research Findings in ALS at 2025 MDA Clinical and Scientific Conference
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of eleven abstracts covering research in amyotrophic lateral sclerosis (ALS) at the 2025 Muscular Dystrophy Association ...